Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $949.59 MXN
Change Today +11.79 / 1.26%
Volume 9.5K
MRK* On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 4:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter N. Kellogg BSE, MBA

Former Chief Financial Officer and Executive Vice President, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 6 different industries.

See Board Relationships
58$10,097,444
As of Fiscal Year 2014

Background*

Mr. Peter N. Kellogg, BSE, MBA has been the Chief Financial Officer and Executive Vice President at Celgene Corporation since August 1, 2014 and July 2014 respectively. Mr. Kellogg served as Executive Vice President of Merck & Co. Inc. from August 14, 2007 to May 16, 2014 and served as its the Chief Financial Officer from August 14, 2007 to April 23, 2014. He served as the Chief Financial Officer and Executive Vice President of Finance at Biogen Idec Inc. since November ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

2007-Present
Director and Member of Audit Committee

Education*

BSE 1978
Princeton University
MBA 1982
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

Salary$400,000
Total Annual Compensation$400,000

Stock Options*

Restricted Stock Awards$5,815,094
All Other Compensation$9,098
Unexercisable Options121,935
Total Number of Options121,935

Total Compensation*

Total Annual Cash Compensation$969,098
Total Short Term Compensation$400,000
Other Long Term Compensation$5,824,192
Total Calculated Compensation$10,097,444
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK*:MM $949.59 MXN +11.79

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.